Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Lindberg

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2024
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of SarcomaIngegerd Öfverholm, Karin Wallander, Cecilia Haglund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2016
Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 SubtypesJingmei Li, Emma Ivansson, Daniel Klevebring, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2014
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomyHelle Kristensen, Christa Haldrup, Siri Strand, et al.
The New England Journal of Medicine|September 17, 2025
Low-Dose Aspirin for PI3K-Altered Localized Colorectal CancerAnna Martling, Ida Hed Myrberg, Mef Nilbert, et al.
Cancer|April 24, 2013
Genetic markers associated with early cancer-specific mortality following prostatectomyWennuan Liu, Chunmei C Xie, Christopher Y Thomas, et al.
Nature Genetics|March 8, 2016
Gene regulatory mechanisms underpinning prostate cancer susceptibilityThomas Whitington, Ping Gao, Wei Song, et al.
The Journal of Clinical Investigation|December 5, 2017
Differential impact of RB status on E2F1 reprogramming in human cancerChristopher McNair, Kexin Xu, Amy C Mandigo, et al.
Molecular Biosystems|April 26, 2008
Correlation network analysis for data integration and biomarker selectionAram Adourian, Ezra Jennings, Raji Balasubramanian, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injuryMaria Mikus, Kimi Drobin, Marcus Gry, et al.
Molecular Oncology|July 5, 2017
Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancerLinnéa Malgerud, Johan Lindberg, Valtteri Wirta, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2024
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of SarcomaIngegerd Öfverholm, Karin Wallander, Cecilia Haglund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2016
Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 SubtypesJingmei Li, Emma Ivansson, Daniel Klevebring, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2014
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomyHelle Kristensen, Christa Haldrup, Siri Strand, et al.
The New England Journal of Medicine|September 17, 2025
Low-Dose Aspirin for PI3K-Altered Localized Colorectal CancerAnna Martling, Ida Hed Myrberg, Mef Nilbert, et al.
Cancer|April 24, 2013
Genetic markers associated with early cancer-specific mortality following prostatectomyWennuan Liu, Chunmei C Xie, Christopher Y Thomas, et al.
Nature Genetics|March 8, 2016
Gene regulatory mechanisms underpinning prostate cancer susceptibilityThomas Whitington, Ping Gao, Wei Song, et al.
The Journal of Clinical Investigation|December 5, 2017
Differential impact of RB status on E2F1 reprogramming in human cancerChristopher McNair, Kexin Xu, Amy C Mandigo, et al.
Molecular Biosystems|April 26, 2008
Correlation network analysis for data integration and biomarker selectionAram Adourian, Ezra Jennings, Raji Balasubramanian, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injuryMaria Mikus, Kimi Drobin, Marcus Gry, et al.
Molecular Oncology|July 5, 2017
Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancerLinnéa Malgerud, Johan Lindberg, Valtteri Wirta, et al.
Pageof 11